Extracellular vesicle-derived microRNAs in pancreatic juice as biomarkers for detection of pancreatic ductal adenocarcinoma
Open Access
- 14 May 2022
- journal article
- research article
- Published by Elsevier in Pancreatology
- Vol. 22 (5) , 626-635
Abstract
No abstract availableKeywords
This publication has 51 references indexed in Scilit:
- Analysis of serum exosomal microRNAs and clinicopathologic features of patients with pancreatic adenocarcinomaWorld Journal of Surgical Oncology, 2013
- MicroRNA-21 in Pancreatic Ductal Adenocarcinoma Tumor-Associated Fibroblasts Promotes MetastasisPLOS ONE, 2013
- Screening for Pancreatic CancerAnnals of Surgery, 2013
- International Cancer of the Pancreas Screening (CAPS) Consortium summit on the management of patients with increased risk for familial pancreatic cancerGut, 2012
- Hepatocyte-derived MicroRNAs as Serum Biomarkers of Hepatic Injury and Rejection after Liver TransplantationLiver Transplantation, 2011
- Combination of plasma microRNAs with serum CA19‐9 for early detection of pancreatic cancerInternational Journal of Cancer, 2011
- MicroRNA-mediated regulation of pancreatic cancer cell proliferationOncology Letters, 2010
- MicroRNA-21 modulates biological functions of pancreatic cancer cells including their proliferation, invasion, and chemoresistanceMolecular Cancer Therapeutics, 2009
- Systematic review of carbohydrate antigen (CA 19-9) as a biochemical marker in the diagnosis of pancreatic cancerEuropean Journal of Surgical Oncology, 2007
- Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT MethodMethods, 2001